TissueScan, Lung Cancer cDNA Array III

SKU
HLRT103
48 samples covering 8-normal, 6-Stage IA, 6-IB, 3-IIA, 8-IIB, 5-IIIA, 5-IIIB, 7-IV. Available in 2, 5, 10 identical plates.
  $1,060.00
In Stock*
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Lung Cancer cDNA Array III
Clinical Info
Diagnosis Category Lung Cancer
Tissue Lung
Shipping Ambient
Description 48 samples covering 8-normal, 6-Stage IA, 6-IB, 3-IIA, 8-IIB, 5-IIIA, 5-IIIB, 7-IV. Available in 2, 5, 10 identical plates.
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Unveiling epithelial plasticity regulation in lung cancer: Exploring the cross-talk among Tks4 scaffold protein partners
László, Kurilla, Tilajka et al
Mol Biol Cell (2024) 35 (8), ar111 DOI: 10.1091/mbc.E24-03-0103
AI Summary: OriGene’s Cancer cDNA Array III (catalog no.: HLRT103) was used in this study to analyze Tks4 mRNA expression across normal and various stages of lung cancer samples, enabling the authors to correlate Tks4 levels with disease progression.
Snippet: Cancer cDNA Array III (Origene, catalog no.: HLRT103) as in the following articles (Jiang et al., 2014;Wu et al., 2019). The Lung Cancer cDNA Array is commercially available in a ready-to-use array format, all the (normal and cancerous) human samples on the array were collected, processed, and sold by Origene. …
SKA2-mediated transcriptional downregulation of the key enzyme of CoQ10 biosynthesis PDSS2 in lung cancer cells
Xia, Tao, Du et al
J Cancer (2023) 14 (3), 379-392 DOI: 10.7150/jca.79058
Cited by 4
AI Summary: OriGene's TissueScan lung cancer panels (HLRT103), which contain prepared cDNAs, were used in this study to analyze PDSS2 expression levels in lung cancer samples, contributing to the investigation of SKA2-PDSS2 regulatory mechanisms.
Snippet: …Collectively, our results demonstrated that PDSS2 is a novel downstream target gene of SKA2 in lung cancer cells, and the SKA2-PDSS2 transcriptional regulatory axis functionally contributes to human lung cancer cell malignant phenotypes and prognosis. The author(s);- TissueScan lung cancer panels (HLRT103) containing prepared cDNAs were purchased from OriGene (Rockville, MD). …
FigureFigureFigure
Epigenetic Silencing of Ubiquitin Specific Protease 4 by Snail1 Contributes to Macrophage-Dependent Inflammation and Therapeutic Resistance in Lung Cancer
Lai, Yeh, Lu et al
Cancers (Basel) (2020) 12 (1) DOI: 10.3390/cancers12010148
Cited by 25
AI Summary: In this study, OriGene products—including the USP4 shRNA (TG311662) and USP4 cDNA plasmid (RC200177)—were used to manipulate USP4 expression in lung cancer cells, enabling the authors to investigate USP4's role in inflammation, stemness, and therapeutic resistance.
Snippet: There is a positive feedback loop driving tumorigenesis and tumor growth through coordinated regulation of epigenetics, inflammation, and stemness. Nevertheless, the molecular mechanism linking these processes is not well understood. In this study, we analyzed the correlation
Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor
Wu, Huang, Hsieh et al
Mol. Cell (2019) 77 (2), 213-227.e5 DOI: 10.1016/j.molcel.2019.10.023
AI Summary: OriGene’s TissueScan Lung Cancer Tissue qPCR Panels I-IV (HLRT101, HLRT102, HLRT103, HLRT104) were used in this study to analyze SUCNR1 expression across lung cancer tissue samples, helping to demonstrate elevated SUCNR1 levels in lung cancer patients compared to controls.
Snippet: issueScan Lung Cancer Tissue qPCR Panels I OriGene Technologies HLRT101 TissueScan Lung Cancer Tissue qPCR Panels II OriGene Technologies HLRT102 TissueScan Lung Cancer Tissue qPCR Panels III OriGene Technologies HLRT103 TissueScan Lung Cancer Tissue qPCR Panels IV OriGene Technologies HLRT104
Crabp2 Promotes Metastasis of Lung Cancer Cells via HuR and Integrin β1/FAK/ERK Signaling
Wu, Lin, Tseng et al
Sci Rep (2019) 9 (1), 845 DOI: 10.1038/s41598-018-37443-4
AI Summary: OriGene’s lung cancer cDNA arrays (HLRT101, HLRT103, and HLRT105) were used in this study to analyze Crabp2 expression in lung cancer samples, contributing to the investigation of its role in metastasis.
Snippet: The lung cancer cDNA arrays (HLRT101, HLRT103, and HLRT105) were from OriGene. Lung cancer tissue arrays were from Super Bio-Chips (CC5). Blood buffy coat cellular RNAs from 50 healthy people and 49 lung cancer patients were obtained from NRPB lung cancer tissue bank, which obtained informed consent from patients
B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer
Jin, Zhu, Cai et al
Int J Mol Sci (2017) 18 (6) DOI: 10.3390/ijms18060860
AI Summary: In this study, OriGene products—including the B-Myb expression plasmid (RC216307) and B-Myb shRNA plasmid (TG311591)—were used to manipulate B-Myb levels in lung cancer cells, enabling the authors to demonstrate B-Myb's role in promoting cell growth and motility in non-small cell lung cancer.
Showing 1-6 of 18 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products